The Eph family of receptor tyrosine kinases and the Abl family of non-receptor tyrosine kinases have both been implicated in tissue morphogenesis. They regulate the organization of the actin cytoskeleton in the developing nervous system and participate in signaling pathways involved in axon growth. Both Eph receptors and Abl are localized in the neuronal growth cone, suggesting that they play a role in axon path®nding. Two-hybrid screens identi®ed regions of Abl and Arg that bind to the EphB2 and EphA4 receptors, suggesting a novel signaling connection involving the two kinase families. The association of full-length Abl and Arg with EphB2 was con®rmed by co-immunoprecipitation and found to involve several distinct protein interactions. The SH2 domains of Abl and Arg bind to tyrosine-phosphorylated motifs in the juxtamembrane region of EphB2. A second, phosphorylation-independent interaction with EphB2 involves non-conserved sequences in the C-terminal tails of Abl and Arg. A third interaction between Abl and EphB2 is probably mediated by an intermediary protein because it requires tyrosine phosphorylation of EphB2, but not the binding sites for the Abl SH2 domain. The connection between EphB2 and Abl/Arg appears to be reciprocal. Activated EphB2 causes tyrosine phosphorylation of Abl and Arg, and vice versa. Interestingly, treatment of COS cells and B35 neuronal-like cells with ephrin-B1 to activate endogenous EphB2 decreased the kinase activity of endogenous Abl. These data are consistent with the opposite eects that Eph receptors and Abl have on neurite ougrowth and suggest that Eph receptors and Abl family kinases have shared signaling activities. Oncogene (2001) 20, 3995 ± 4006.
Introduction
Abl was one of the ®rst protein tyrosine kinases to be discovered (Sefton et al., 1981; Witte et al., 1980) . However, neither its role in cell transformation nor its normal cellular functions are completely understood. Abl was identi®ed as v-Abl, the transforming protein of Abelson murine leukemia virus (Go, 1985; Rosenberg, 1982) and c-Abl is the corresponding normal cellular gene (Wang et al., 1984) . Abl is a non-receptor tyrosine kinase with multiple functional regions, including a Src homology 3 (SH3), Src homology 2 (SH2), a tyrosine kinase domain, and a C-terminal tail that contains binding motifs for SH3 domains, DNA, ®lamentous F-actin, and monomeric G-actin (Van Etten, 1999; Wang, 1993) . Nuclear localization and nuclear export motifs are also present in the C-terminal tail of Abl. Recombination of the Abl gene with the BCR gene produces the BCR-Abl fusion protein, which has deregulated kinase activity and causes human leukemias (Mes-Masson et al., 1986; Shtivelman et al., 1985) .
Because of its role in human disease and cell transformation, Abl has been intensively studied for over two decades. Cellular c-Abl, which is predominantly localized in the nucleus of many cultured cells (Van Etten et al., 1989) , was shown to play a role in cell cycle progression, gene transcription, cellular responses to DNA damage, and activation of mitogen-activated protein (MAP) kinases (Van Etten, 1999; Wang, 1998) . Surprisingly, however, Abl-de®cient cells do not exhibit growth abnormalities (Liu et al., 1996) , suggesting that the nuclear functions of Abl are not essential and can be carried out by other proteins.
Arg (Abl-related gene) (Kruh et al., 1986 (Kruh et al., , 1990 ) shares considerable structural and sequence homology with Abl in the N-terminal portion consisting of the SH3, SH2, and kinase domains. The C-terminal tail of Arg, although it also contains binding motifs for SH3 domains, F-actin, and G-actin, is fairly divergent from that of Abl. Furthermore Arg, unlike Abl, is predominantly localized in the cytoplasm . This diversity may re¯ect speci®c functions in each of the two proteins.
Recently, analysis of Abl/Arg double knock-out mice have oered insight into the function of these two proteins. Cells derived from the double knock-out mice did not exhibit growth defects or abnormalities in their responses to DNA damage caused by ionizing radiation (Koleske et al., 1998) . In contrast, the abnormalities observed in the double knock-out mice suggest that the cytoplasmic functions of Abl and Arg are essential (Koleske et al., 1998) . Severe defects were observed in the nervous system, including malformations and delayed closure of the neural tube. The nature of these defects suggest that Abl and Arg regulate cell shape and actin organization. Indeed, Arg and a substantial proportion of Abl are associated with actin ®laments in vivo in developing neuroepithelial cells. Behavioral studies with Arg knock-out mice also demonstrated that Arg is required for normal brain function. Interestingly, Arg is preferentially expressed in brain regions rich in axons and synapses rather than neuronal cell bodies. However, analysis of the Arg knock-out mice has not revealed gross anatomical abnormalities, but additional experiments may be required to identify more subtle defects in axonal path®nding.
Additional knock-out studies have demonstrated that several genes linked to Abl signaling pathways are critical for mammalian neural development (Van Etten, 1999) . Mena, a gene identi®ed in Drosophila as a suppressor of Abl phenotypes (Gertler et al., 1990) , is required for the proper path®nding of brain commissural axons (Lanier et al., 1999) . Disabled, a gene identi®ed in Drosophila as a dose-dependent modi®er of Abl (Gertler et al., 1993) , and p35/Cdk5, a kinase complex recently implicated in Abl downstream signaling pathways (Van Etten, 1999; Zukerberg et al., 2000) , are both required for neuronal cell migration in the developing cortex (Chae et al., 1997; .
The results of two-hybrid screens brought to our attention that Eph receptors could bind Abl and Arg and may, therefore, regulate their activity´Eph is a large family of receptor tyrosine kinases Holder and Klein, 1999; Pasquale, 1997) . Their activating ligands are the ephrins, which are either GPI-linked or transmembrane proteins. Eph receptor and ephrin genes regulate morphogenetic processes in the developing nervous system (Holder and Klein, 1999) . In particular, analysis of ephrin-A2 and ephrin-A5 knock-out mice revealed defects in neural tube closure as well as defects in path®nding of brain axonal projections (Feldheim et al., 1998 (Feldheim et al., , 2000 Frisen et al., 1998) . Axon guidance defects have similarly been identi®ed in EphA4, EphA8, EphB2, EphB3 and EphB2/EphB3 double knock-out mice (Dottori et al., 1998; Helmbacher et al., 2000; Henkemeyer et al., 1996; Orioli and Klein, 1997; Park et al., 1997) . However, the molecular mechanisms and signaling pathways that the Eph receptors utilize to in¯uence cell behavior remain largely obscure.
Autophosphorylation of intracellular tyrosine residues of receptor tyrosine kinases is crucial for the recruitment of signaling molecules bearing SH2 and phosphotyrosine binding (PTB) domains (van der Geer et al., 1994) . A number of signaling proteins have been identi®ed that interact with Eph receptors and may therefore participate in their signaling pathways (Bruckner and Klein, 1998; Kalo and Pasquale, 1999) . Many of these proteins contain an SH2 domain. They include the adaptors SLAP (Pandey et al., 1995) , Grb2, Grb10 (Stein et al., 1996) , and Nck (Stein et al., 1998) ; the Ras GTPase-activating protein RasGAP (Holland et al., 1997) ; the p85 subunit of phosphatidylinositol 3-kinase (Pandey et al., 1994) ; the newly identi®ed SHEP1 (SH2 domain-containing Eph receptor-binding protein 1) (Dodelet et al., 1999) ; and nonreceptor tyrosine kinases of the Src family (Ellis et al., 1996; Hock et al., 1998; Zisch et al., 1998) . Here we identify the Abl family as a new family of non-receptor tyrosine kinases that associate with Eph receptors through their SH2 domains. Our data support the intriguing possibility that the Eph and Abl families cooperate to regulate actin dynamics at the leading edge of growing axons.
Results

Two-hybrid screens identify the tyrosine kinases Abl and Arg as potential binding partners of Eph receptors
To identify potential downstream signaling molecules, the cytoplasmic domains of the EphB2 and EphA4 receptors were expressed in yeast as LexA fusion proteins and used as baits in yeast two-hybrid screens. As previously reported, LexA:EphB2 is substantially tyrosine phosphorylated in yeast and has a pattern of in vitro autophosphorylation similar to that of wild type EphB2 (Zisch et al., 1998) . LexA:EphA4 is also phosphorylated, although to a lesser extent (data not shown). In a two-hybrid screen of a VP16 mouse embryo library with LexA:EphB2, we isolated a clone containing the SH2 domain of the non-receptor tyrosine kinase Abl and two independent clones encoding partially overlapping portions of the Cterminal tail of Arg (Table 1 ). An additional clone encoded the Abl SH2 domain, except for the initial three amino acids. In a screen with LexA:EphA4, we isolated a clone containing the SH2 domain of Abl (Table 1) .
Abl is co-expressed with EphB2 in neural tissues
Arg and EphB2 have both been reported to be preferentially expressed in the nervous system (Koleske et al., 1998; Perego et al., 1991) , consistent with the possibility that they interact in vivo. In contrast, Abl is not preferentially expressed in neural tissues (Boulter and Wagner, 1988; Muller et al., 1982) . Like EphB2, however, Abl was detected at substantial levels in the developing chicken brain and retina in immunoblotting experiments (Figure 1 ). This is consistent with the possibility that Abl and EphB2 interact in vivo. Indeed, it was recently reported that mammalian Abl is localized in the growth cones of cultured neurons (Zukerberg et al., 2000) .
Multiple interactions of Abl and Arg with EphB2
To study the molecular basis of the interaction between EphB2 and Abl/Arg, we carried out two-hybrid experiments with a panel of EphB2 mutants ( Figure  2) . A kinase inactive mutant of EphB2 (EphB2 KD) was used to examine the requirement for EphB2 autophosphorylation. To determine the function of the juxtamembrane tyrosine residues 605 and 611 of EphB2 in binding the Abl and Arg SH2 domains, these residues were mutated to glutamic acid individually or in combination. These residues were targeted because their surrounding sequences conform to the consensus binding motif (YXXP) determined for the Abl SH2 domain (Songyang et al., 1993) . Furthermore, tyrosines 605 and 611 are required for association with the SH2 domains of several other SH2 domain-containing signaling proteins . Importantly, mutation of these two tyrosines to glutamic acid, rather than phenylalanine, preserves EphB2 kinase activity (Zisch et al., 2000) .
Association of the Abl SH2 domain was investigated using the VP16 plasmid isolated in the EphA4 twohybrid screen, which encodes the SH2 domain of Abl and additional¯anking sequences (Table 1) . Because the SH2 domains of Abl and Arg are closely related, a VP16 plasmid encoding the SH2 domain of human Arg, without¯anking sequences, was used to investigate binding of the Arg SH2 domain to EphB2. Finally, the VP16 plasmid encoding amino acids 883 ± 975 of the Arg C-terminal tail (Table 1 ) was used to investigate the association of this region of Arg with EphB2. Because wild type EphB2 and the Eph-B2Y611E mutant exhibit some transactivating activity on their own, we analysed the interactions between Abl/Arg and EphB2 using both b-galactosidase color assays and growth assays on histidine-free (THULL) medium. In the growth assays, a competitive inhibitor of the his3 gene, 3-aminotriazole, was used to reduce the background yeast growth caused by some of the LexA:EphB2 baits (Vojtek and Hollenberg, 1995) .
The two-hybrid analyses showed that the SH2 domain of Arg also binds to EphB2. Association of the SH2 domains of Abl and Arg requires tyrosine phosphorylation of EphB2, whereas binding of the Cterminal segment of Arg is phosphorylation-independent. The Abl SH2 domain binds to both the 605 and 611 tyrosine phosphorylated motifs, whereas the Arg SH2 domain exhibits preferential binding to the tyrosine 611 motif.
To con®rm the association of the Abl SH2 domain with full-length EphB2 expressed in mammalian cells, GST pull-down assays were carried out. Extracts of 293T cells transiently transfected with wild type and mutated EphB2 were incubated with an immobilized GST fusion protein of the Abl SH2 domain (GST-Abl Numbering is according to the sequence of mouse Abl type IV (Ben-Neriah et al., 1986) .
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Because the full-length sequence of human but not mouse Arg has been deposited in GenBank, amino acid numbers are those in human Arg IB (Kruh et al., 1990 ) that correspond to the mouse Arg fragment isolated. The sequence of the larger fragment isolated has been deposited in GenBank with accession number AF339052
Interactions of Abl/Arg with the EphB2 receptor H-H Yu et al SH2) ( Figure 3A ). Bound proteins were analysed by immunoblotting with anti-EphB2 antibodies. Wild type EphB2, but not EphB2 KD or EphB2Y605/611E, in which both tyrosines 605 and 611 are mutated to glutamic acid, bound to GST-Abl SH2. These results are consistent with the results obtained in the yeast two-hybrid assays. They con®rm that phosphorylation of tyrosines 605 or 611 is required for binding of the Abl SH2 domain to EphB2 and that the Abl SH2 domain does not interact with other tyrosine phosphorylated motifs of EphB2.
To determine whether the Abl SH2 domain binds EphB2 and other Eph receptors expressed in tissues, extracts from the developing chicken retina were used to perform GST-pull-down assays ( Figure 3B ). We have previously reported that a number of Eph receptors are present and phosphorylated on tyrosine in the developing chicken retina Soans et al., 1996) . As shown in Figure 3B both EphB2 and EphA3 are expressed in the developing chicken retina and were detected in association with immobilized GST-Abl SH2. Our previous studies (Zisch et al., 1998) showed that the SH2 domain of Src binds strongly to EphB2. In comparison, the Abl SH2 domain exhibited as strong an interaction with EphB2 and EphA3 ( Figure 3B ), consistent with the fact that both Src and Abl SH2 domains belong to subgroup 1 and bind somewhat similar amino acid sequences (Songyang and Cantley, 1995) . These results show that Eph receptor phosphorylation sites required for association with the SH2 domain of Abl are present in vivo. The SH2 domain of Abl binds to Eph receptors expressed in the embryonic chicken retina. RIPA extracts of embryonic day 13 chicken retina were incubated with the puri®ed GST SH2 domains of Abl and Src bound to glutathione sepharose. Bound proteins were probed by immunoblotting with anti-EphA3, antiEphB2, and anti-phosphotyrosine (Ptyr) antibodies. The positions of molecular weight standards, in Kd, are indicated on the right Figure 2 Yeast two-hybrid analysis of the interaction between wild type and mutated EphB2 (fused to the LexA DNA binding domain) and dierent regions of Abl or Arg (fused to the VP16 transactivation domain). The yeast reporter strain L40 was cotransformed with the two-hybrid`bait' plasmid pBTM116 encoding the cytoplasmic domain of wild type EphB2, the indicated EphB2 mutants, or lamin as LexA fusion proteins and VP16 encoding the indicated portions of Abl and Arg, or the Abl SH2 antisense sequence (7). The interactions were tested by a bgalactosidase color assay (A) and a growth assay on histidine-free (THULL) medium (B) To characterize the interactions between full-length proteins in living eukaryotic cells, mouse Abl or human Arg were co-transfected into 293T cells with various EphB2 mutants and co-immunoprecipitation experiments were performed. In contrast to the isolated Abl SH2 domain, full-length Abl associated not only with wild type EphB2 but also with EphB2Y605/611E and EphB2 KD, although the signal for Abl in the EphB2 KD immunoprecipitates was slightly weaker ( Figure  4A ). The binding of Abl to EphB2 KD reveals a second interaction that must be mediated by a region of Abl other than the SH2 domain and be phosphorylation-independent. This notion is supported by the result shown in Figure 4B . Insertion of the amino acid sequence GGGGDYKDDDDKGGGGST, containing the FLAG epitope, between amino acid 979 and 980 in the C-terminal tail of Abl abolished the association with EphB2 KD. Thus, in addition to the SH2 domain, a motif in the C-tail of Abl also mediates binding to EphB2 but in a phosphorylation-independent manner.
The FLAG-tagged mutant of Abl, in which the Cterminal binding region was inactivated, still bound to EphB2Y605/611E, which lacks the binding sites for the Abl SH2 domain but retains other tyrosine-phosphorylated motifs. This reveals a third interaction between EphB2 and Abl that requires phosphorylation of a tyrosine dierent from tyrosines 605 and 611. Presumably an intermediary protein containing an SH2 or PTB domain that binds to EphB2 mediates this third interaction.
The association between Arg and EphB2 was also con®rmed by co-immunoprecipitation experiments ( Figure 4C ). Like Abl, Arg interacts with kinase inactive EphB2 KD and with EphB2 Y605/611E. This is consistent with the two-hybrid results, which showed that a segment of the C-terminal tail of Arg binds EphB2 independently of EphB2 tyrosine phosphorylation. Thus, both Abl and Arg interact with EphB2 at multiple sites.
Reciprocal phosphorylation of Abl/Arg and EphB2
Because Abl and Arg bind to EphB2, they likely play a role in EphB2 signaling. To investigate how EphB2 could in¯uence Abl and Arg, we examined whether these kinases become phosphorylated on tyrosine in cells expressing activated EphB2. Tyrosine phosphorylation of wild type Abl was detected in the presence of wild type EphB2 but not EphB2 KD ( Figure 5A ). Similar results were obtained with Arg ( Figure 5B ). Kinase inactive Abl (Abl KD) also became phosphorylated on tyrosine in the presence of EphB2 (Figure 5A ), excluding the possibility that the increased level of Abl tyrosine phosphorylation was caused by autophosphorylation. Taken together, these results suggest that EphB2, and/or tyrosine kinases activated downstream of EphB2, phosphorylate Abl and Arg. Abl and Arg, therefore, likely are downstream components of EphB2 signaling pathways.
We also noticed, however, that in cells cotransfected with Arg and EphB2, a tyrosine phosphorylated band corresponding in size to EphB2 was present in Arg immunoprecipitates ( Figure 4C ). This band was present not only in cells transfected with wild type EphB2 but also, although less prominent, in Figure 4 Physical association between EphB2 and Abl or Arg. The indicated EphB2 expression constructs, or pcDNA3 (7), were co-transfected into 293T cells with Abl (A), Abl containing the FLAG tag between amino acids 979 and 980 in the C-terminal tail (B), or Arg tagged at the N terminus with the Myc epitope (Arg-Myc) (C). Cell lysates were immunoprecipitated with antiEphB2 antibody. The immunoprecipitates were separated by SDS ± PAGE and probed by immunoblotting with anti-Abl or anti-Myc antibodies, followed by reprobing with anti-EphB2 antibody, and then re-probing with anti-phosphotyrosine (PTyr) antibody. The positions of molecular weight standards, in Kd, are indicated on the right cells transfected with EphB2 KD. To determine whether Arg can cause the tyrosine phosphorylation of EphB2, we examined tyrosine phosphorylation of EphB2 KD in the presence or absence of cotransfected Abl or Arg (Figure 6 ). Probing EphB2 immunoprecipitates and cell lysates with anti-phosphotyrosine antibodies showed that EphB2 KD was phosphorylated in the presence of wild type Abl or Arg but not in the presence of kinase inactive Abl KD. Taken together with the results shown in Figure 5 , this suggests a reciprocal interaction between EphB2 and Abl/Arg, in which EphB2 causes tyrosine phosphorylation of Abl and Arg while Abl and Arg cause tyrosine phosphorylation of EphB2.
Ephrin-B1 regulates Abl kinase activity
Receptor tyrosine kinases exert some of their eects by activating cytoplasmic tyrosine kinases with which they interact (van der Geer et al., 1994) . Abl kinase activity is upregulated following activation of the platelet-derived growth factor (PDGF) receptor (Plattner et al., 1999) . To determine whether Abl kinase activity is also upregulated by EphB2, we used COS cells and the neuronal-like B35 cells (Schubert et al., 1974) , which contain substantial levels of endogenous EphB2 and Abl. The COS and B35 cells were treated with ephrin-B1, which is a ligand for EphB receptors ± including EphB2 . Following ephrin-B1 stimulation, endogenous Abl was immunoprecipitated at dierent time points to measure its ability to phosphorylate a protein substrate in vitro. As a substrate we used GST fused to a fragment of the adaptor Crk. This Crk fragment contains only one tyrosine, Y221, which has been previously shown to be an excellent substrate for Abl (Feller et al., 1994) . Unexpectedly, we found that in both COS and B35 cells ephrin-B1 caused a transient decrease, rather than an increase, in Abl kinase activity (Figure 7) . This decrease, which we quantitated by measuring the decrease in tyrosine phophorylation of GST-Crk, occurred within a few minutes, with a slightly faster time course in B35 cells than in COS cells. These results show that Abl activity is regulated by ephrinmediated Eph receptor activation. 
Discussion
Here we describe the novel molecular interaction and signaling connection between Eph receptors and Abl family kinases. We discovered that Abl/Arg and EphB2 physically interact and reciprocally phosphorylate each other. Other than the report that an Abl GST fusion protein bound to the EGF receptor (Zhu et al., 1994) , there has been no evidence to suggest that Abl participates in receptor tyrosine kinase signaling pathways (Van Etten, 1999) . During preparation of this manuscript, however, Abl was reported to associate with the nerve growth factor receptor TrkA (Koch et al., 2000; Yano et al., 2000) and has been implicated in the cellular response to PDGF (Plattner et al., 1999) .
Interestingly, we found that Abl kinase activity transiently decreases when EphB2 kinase activity is stimulated by ephrin-B1. To our knowledge this is the Figure 7 Ephrin-B1 causes a transient decrease in Abl kinase activity. COS cells (A,B) or B35 cells (C,D) were grown overnight in serum-free medium and stimulated with 2 mg/ml pre-clustered ephrin-B1 Fc for the indicated times (in min). The 0 min time point represents cells that were not treated with ephrin-B1. Abl was immunoprecipitated from the cell lysates and subjected to in vitro kinase reactions to measure its ability to phosphorylate a GST-Crk substrate. After SDS ± PAGE, the tyrosine phosphorylation levels of GST-Crk (CrkY221-YP) were detected by immunoblotting with anti-phosphotyrosine antibodies. The amounts of GST-Crk (CrkY221) were veri®ed by amido black staining of the membranes before immunoblotting; the amounts of immunoprecipitated Abl were veri®ed by immunoblotting with anti-Abl antibodies. The levels of EphB2 tyrosine phosphorylation (EphB2-YP) and EphB2 protein are also shown for the B35 cells. Control lanes include a lane in which Abl was immunoprecipitated from cells that were not treated with ephrin-B1 and ATP was omitted from the kinase reaction (-ATP), a lane in which the immunoprecipitation was carried out from cells not treated with ephrin-B1 using non-immune mouse IgGs (7), and a lane in which the GST-Crk fusion protein was not incubated with immunoprecipitated Abl and ATP (CrkY221). The arrow in (C) indicates the position of GST-Crk. (B, D) The tyrosine phosphorylation of GST-Crk was quantitated from three dierent experiments using NIH Image software and is shown relative to the phophorylation of GST-Crk that was observed without ephrin-B1 stimulation. The points represent averages of three experiments for both COS7 cells and B35 cells. The experiment shown in (A) was included in the analysis in (B), whereas the experiment shown in (C) is a fourth experiment, in addition to the three quantitated in (D). Bars represent standard errors ®rst instance in which an increase in activity of a receptor tyrosine kinase causes a decrease in activity of a cytoplasmic tyrosine kinase. How ephrin-B1 downregulates Abl activity through EphB receptors remains to be determined. Perhaps tyrosine phosphorylation of Abl downstream of EphB2 inhibits Abl kinase activity. Abl tyrosine phosphorylation following cell matrix adhesion or PDGF receptor activation has been correlated with increased kinase activity (Lewis and Schwartz, 1998; Plattner et al., 1999) . However, the eects of Abl phosphorylation may depend on which tyrosines become phosphorylated, as is the case for Src (Superti-Furga and Courtneidge, 1995) .
In addition to modulating their activity, tyrosine phosphorylation of Abl and Arg downstream of EphB2 could regulate their interaction with other proteins. Docking proteins of the Dok family, such as p62 dok and DOKL, bind to tyrosine-phosphorylated Abl through their PTB domain and are very good substrates for Abl (Cong et al., 1999; Yamanashi and Baltimore, 1997) . Perhaps Abl mediates the tyrosine phosphorylation of p62 dok downstream of EphB2 (Holland et al., 1997) , causing the formation of a signaling complex including p62 dok , RasGAP, the adaptor Nck, and the Nck interacting kinase NIK (Becker et al., 2000; Holland et al., 1997) .
Abl and Arg not only become phosphorylated on tyrosine when EphB2 is activated, they in turn also cause EphB2 phosphorylation. This may lead to a synergistic relationship between Abl/Arg and EphB2, analogous to that recently proposed for the epidermal growth factor (EGF) receptor tyrosine kinase and the Src non-receptor tyrosine kinase (Tice et al., 1999) . Activation of the EGF receptor results in association with Src, which in turn phosphorylates the EGF receptor at tyrosine 845 in the activation loop. This Src-induced phosphorylation was shown to be essential for the mitogenic response to EGF (Tice et al., 1999) . Similarly, phosphorylation of EphB2 by Abl and Arg could modulate EphB2 function, particularly if the phosphorylated tyrosine(s) are poor EphB2 autophosphorylation sites.
We identi®ed multiple domains that mediate interactions between Abl/Arg and EphB2. Although multiple interactions between two signaling proteins are unusual, there are precedents for this type of interaction in the case of Abl. The association between Abl and the recently described Cables protein involves the SH3 domain of Abl as well as multiple other regions of Abl (Zukerberg et al., 2000) . In addition, the interaction between Abl and the Abi-2 protein involves the SH3 domain as well as the C-terminal region of Abl (Dai and Pendergast, 1995) . Three dierent regions of Abl and at least two regions of Arg interact with dierent regions of EphB2. Abl and Arg bind to EphB2 independently of phosphorylation through their C-terminal tail and to tyrosine phosphorylated motifs of EphB2 through their SH2 domain and likely also through a third region.
The Abl and Arg SH2 domains require the phosphorylated tyrosine 605 and 611 motifs of activated EphB2, which conform to the preferred YXXP binding sequence for the Abl SH2 domain (Songyang et al., 1993) . These sites are highly conserved within the Eph family, and in agreement with this we have found that the SH2 domain of Abl associates with other Eph receptors, such as EphA3 and EphA4. Interestingly, although the sequence identity between the Abl and Arg SH2 domains is very high (89% at the amino acid level), their binding preference for the motifs containing tyrosines 605 and 611 of EphB2 is somewhat dierent. Previous domain swapping experiments have indeed shown that the Abl and Arg SH2 domains are not functionally equivalent (Muller et al., 1993) . Interestingly, the fact that Abl and Arg also bind to other regions of Eph receptors may favor their association compared to other proteins that bind to the same juxtamembrane sites. The SH2 domains of Src family kinases, Nck, SHEP1, and p120 RasGAP, for example, have been shown to bind one or both of the tyrosine phosphorylated motifs to which the Abl and Arg SH2 domains also bind .
Another interaction between Abl and EphB2 requires tyrosine phosphorylation of EphB2, but not the binding sites for the Abl SH2 domain. An Ablinteracting protein whose association with EphB2 does not require tyrosines 605 or 611 is likely to be involved. A possible candidate is the adaptor protein Crk, which associates with Abl and Arg through its SH3 domain (Feller et al., 1994; Ren et al., 1994; and through its SH2 domain binds to an unknown site that does not include tyrosines 605 and 611 (Zisch et al., 2000) . On the other hand, the adaptor Nck is not a good candidate because it requires the tyrosine corresponding to tyrosine 605 of EphB2 for binding (Becker et al., 2000; Stein et al., 1998) .
Why Abl engages in multiple binding interactions with other proteins is still a matter of speculation. Multiple binding sites may serve to ®nely regulate the binding anity of Abl with other proteins according to the conditions in the cell. The binding of Abl and Arg to inactive non-tyrosine phosphorylated EphB2, for example, is presumably stabilized by the additional phosphorylation-dependent interactions occurring when EphB2 becomes activated. In addition to strengthening the association with EphB2, binding of the Abl and Arg SH2 domains to EphB2 could prevent Abl and Arg from engaging in processive interactions with substrate proteins (Mayer et al., 1995) . Together with the decrease in Abl kinase activity, this could contribute to inhibiting Abl/Arg signaling capacity in cells in which Eph receptors become activated. Our results suggest that EphB2 and Abl/Arg control axon behavior through shared signaling pathways. Upregulation of EphB2 and downregulation of Abl kinase activity following ephrin-B1 treatment are consistent with the known opposite eects of these kinases on neurite outgrowth. Activation of Eph receptors in neurons typically has repulsive and inhibitory eects on neurite outgrowth . In contrast, activated Abl in cultured neurons promotes neurite outgrowth (Zukerberg et al., 2000) . A number of other ®ndings further support the idea that the interaction between Abl/Arg and EphB2 has a functional relevance. Arg, like EphB2, is highly expressed in the brain (Perego et al., 1991) and interestingly, both proteins are concentrated in the molecular layer of the cerebellum and the process-rich layers of the hippocampus (Dalva et al., 2000; Koleske et al., 1998; Pasquale et al., 1992) . Furthermore, as we show here, Abl is co-expressed at substantial levels with EphB2 in the developing brain and retina and both are expressed in postmitotic neurons and localized to the growth cone (Holash and Pasquale, 1995; Zukerberg et al., 2000) .
Eph receptor and Abl/Arg signaling likely aect axon behavior through changes in cell adhesion and organization of the actin cytoskeleton. Activation of Eph receptors by ephrins in cultured cortical neurons, for example, disrupts the organization of the actin cytoskeleton (Meima et al., 1997a,b) . Eph receptor activity also in¯uences actin cytoskeleton dynamics and cell adhesion in non-neuronal cells (Huynh-Do et al., 1999; Miao et al., 2000; Zisch et al., 2000; Zou et al., 1999) . Abl and Arg were recently shown to regulate actin organization in embryonic neuroepithelial cells (Koleske et al., 1998) . Abl also mediates actin cytoskeleton remodeling downstream of the PDGF receptor (Plattner et al., 1999) . In addition, a constitutively active oncogenic form of Abl, Bcr/Abl, causes rapid formation and retraction of actin extensions and decreased integrin activity in cultured cells (Salgia et al., 1997) . In Drosophila, genetic interactions have been demonstrated between Abl and several genes known to modulate actin ®lament dynamics (Comer et al., 1998; Hill et al., 1995; Wills et al., 1999) . Furthermore, both Abl and Arg contain actin-binding regions. In Abl, the actin binding region is located at the extreme Cterminus and has been shown to control F-actin bundling in vitro (Van Etten, 1999) .
Abl has been recently proposed to regulate neurite outgrowth through an adaptor protein called Cables, which links Abl to cyclin-dependent kinase 5 (Cdk5) and facilitates Cdk5 phophorylation and activation by Abl (Zukerberg et al., 2000) . Cdk5 is a small serine/ threonine kinase that regulates the actin cytoskeleton and plays an essential role in neurite outgrowth during neuronal dierentiation (Nikolic et al., 1996 (Nikolic et al., , 1998 . It will be interesting to determine whether ephrin-B1 aects Cdk5 activity through EphB receptors.
Our ®ndings contribute to the understanding of the signaling pathways involving Abl and Arg. The multiple, dierentially regulated binding interactions between EphB2 and Abl/Arg, the ability of these proteins to phosphorylate each other, and their opposite changes in activity upon ephrin-B1 stimulation suggest complex molecular interactions that regulate cell signaling. Further elucidation of the functional relationship between the Eph and Abl families of tyrosine kinases in neurons will provide critical insights into how neuronal connections are established.
Materials and methods
Antibodies
Anity-puri®ed polyclonal antibodies to GST-EphB2 (amino acids 897 ± 995) and to a C-terminal peptide of EphA3 were generated as previously described (Holash et al., 1997; Soans et al., 1994) . The anti-Abl monoclonal antibody, 8E9, was kindly provided by Dr Jean Wang and the anti-Abl monoclonal antibody, Ab-3, was from Oncogene Research Products. The anti-Myc monoclonal antibody, 9E10, was from Santa Cruz Biotechnology. Horseradish-conjugated anti-phosphotyrosine antibody PY20 was from Transduction Laboratories and horseradish-conjugated goat anti-mouse antibody was from Jackson ImmunoResearch Laboratories.
Plasmids
The yeast two-hybrid plasmids LexA:EphB2, LexA:Eph-B2Y605E, LexA:EphB2Y611E, LexA:EphB2Y605/611E, Lex-A:EphB2 KD, and LexA:lamin and the pcDNA3 plasmids encoding wild type and mutated forms of full-length EphB2 have been described (Zisch et al., 1998 (Zisch et al., , 2000 .
Full-length mouse Abl type IV wild type and kinase inactive clones, both with a FLAG epitope inserted between amino acids 979 and 980 (Ben-Neriah et al., 1986) , were provided by Dr Jean Wang. The Abl sequences were subcloned between the EcoRI and NotI sites of pcDNA3. To remove the FLAG epitope from the Abl wild type clone, a portion of the 3' region was ampli®ed from a mouse 15-day embryonic library (Clontech) by PCR using the sense primer GGATCCTGCCGTCTGCTGGCAAG, which corresponds to nucleotides 2467 ± 2485 of c-Abl and includes a BamHI site (underlined), and the antisense primer CGGAATTC-TACCTCCGGACAATGTC, which corresponds to nucleotides 3625 ± 3608 of c-Abl and includes an EcoRI restriction site (underlined). The ampli®ed fragment was digested with StuI (nt 2837) and EcoRI (3' end) and cloned into pBluescript SK + between the EcoRI and EcoRV sites. The resulting construct was digested with ApaI (nt 3012) and XbaI (in the pBluescript SK + polylinker). This ApaI to XbaI fragment was used, together with an Abl fragment generated by XhoI (nt 2460) and ApaI (nt 3012) digestion, to replace the region from XhoI (nt 2460) to XbaI (3' end) in plasmid Abl-FLAG in pcDNA3 so as to generate a full-length Abl wild type clone. The same strategy was used to remove the FLAG tag from kinase inactive Abl.
To obtain the SH2 domain of Abl as a GST fusion protein, the VP16 Abl SH2 clone isolated in the EphA4 screen (Table  1 ) was used as the template for PCR ampli®cation with the sense primer GAGCGGATCCTGGTATCATGGCCCTGT (corresponding to nt 629 ± 648 and including a BamHI site which is underlined) and the antisense primer GGAATT-CAGTGGGCTTGTTGCGCT (corresponding to nt 909 ± 925 and including an EcoRI site which is underlined). The ampli®ed fragment was digested with EcoRI and BamHI and subcloned into EcoRI and BamHI digested pGEX-4T1 plasmid.
A plasmid encoding full-length human Arg type IB (CMVArg IB) (Kruh et al., 1990 ) was a gift from Dr Gary Kruh. To obtain Arg SH2 in VP16, a fragment corresponding to the Arg SH2 domain was ampli®ed with the sense primer CGGGATCCACTCCTGGTACCATGG (Arg SH2 5', with the introduced BamHI site underlined) and the antisense primer GGAATTCTGTAGGCTTATTACACTT (Arg SH2 3', with the introduced Eco RI site underlined) using CMVArg IB as the template. The BamHI and EcoRI digested PCR product was cloned into the corresponding sites of the pVP16 plasmid.
To obtain the construct encoding Myc-tagged full-length Arg, a 5' end fragment of Arg was ampli®ed from CMV-Arg IB using the sense primer GGAATTCATGGGGCAG-CAGGTGGGC (with the introduced EcoRI site underlined) and Arg SH2 3'. The PCR fragment was digested with EcoRI, cloned into the EcoRI site of a pcDNA3-Myc vector and screened for orientation. A KpnI (nt 721) to ApaI (in pcDNA3) fragment was obtained from Arg IB in pcDNA3 and ligated into the EcoRI and ApaI digested pcDNA3-Myc vector containing the 5' Arg fragment.
To obtain the Arg C terminus in VP16, one of the two independent clones isolated in the two-hybrid screen (encoding amino acids 883 ± 975 (Table 1) ) was ampli®ed by PCR with VP16 speci®c primers, puri®ed, digested with NotI, and subcloned back into the NotI site of VP16. Clones were then screened for orientation.
The GST-Crk construct was a gift from Drs Yama Abassi and Kristiina Vuori. It includes amino acids 191(Arg) ± 283(Ile) of rat CrkII.
Yeast two-hybrid
The screening of an E9.5-10.5 mouse embryo library was carried out essentially as described (Vojtek and Hollenberg, 1995) . Brie¯y, the L40 yeast strain was ®rst transformed with the LexA:EphB2 construct, and this resulting strain was then used for transformation with the VP16 mouse embryo library. Co-transformants were selected for growth on THULL (tryptophan, histidine, uracil, leucine, lysine-de®-cient) media supplemented with 15 mM 3-aminotriazole. Clones were re-streaked onto a master plate and the library inserts ampli®ed by PCR using VP16 speci®c primers. Products were ®rst puri®ed using the QIAquick PCR puri®cation kit (Qiagen), followed by size veri®cation by agarose gel electrophoresis. Products were then sequenced and identi®ed by BLAST searching.
For analysis of the interaction between wild type and mutated EphB2 and various fragments of Abl and Arg, the L40 yeast strain was co-transformed with LexA and VP16 constucts. Co-transformants were ®rst selected on uracil, leucine, tryptophan-de®cient medium and then tested for interaction by both b-galactosidase color assays as described (Duttweiler, 1996) and growth assays on histidine-de®cient THULL medium as previously described (Zisch et al., 1998) .
Cell culture, transfection and ephrin-B1 treatment
The 293T human embryonal kidney cells, COS7 green monkey cells, and B35 neuronal-like cells were maintained in Dubecco's modi®ed Eagle's medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 1 mM sodium pyruvate, 50 units/ml penicillin and 50 mg/ml streptomycin at 378C. Superfect (Qiagen)-mediated transfections were carried out according to the manufacturer's instructions. Twentyfour to 36 h post-transfection, 293T cells were scraped o the plate and harvested in ice-cold PBS, collected by centrifugation and immediately frozen on dry ice. COS7 and B35 cells were incubated overnight with OPTIMEM reduced serum medium (GIBCO BRL) without serum. Ephrin-B1 Fc (Holash et al., 1997) was preclustered with anti-Fc antibody at a 1 : 10 ratio for 30 min on ice and added to the cell culture medium at a ®nal concentration of 2 mg/ml. The cells were collected in RIPA buer at dierent times after ephrin-B1 addition.
GST binding assays
GST and GST Abl SH2 domain were expressed in bacteria and puri®ed on glutathione-agarose beads. The 293T cells transiently transfected with EphB2 wild type or mutated forms were lysed in RIPA buer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA) containing 400 mM sodium pervanadate (Zisch et al., 1997) , 1 mM PMSF, 10 mg/ml protease inhibitors and 5 mM DTT. All the forms of EphB2 that were transfected, except for kinase inactive EphB2, were phosphorylated on tyrosine in the 293T cells (Zisch et al., 2000) . The extracts were precleared with GST immobilized on glutathione sepharose for 30 min at 48C on a rotating wheel, followed by incubation with immobilized GST-Abl SH2 or GST for 1 h at 48C. Proteins bound to the beads were subjected to SDS ± PAGE and transferred to polyvinylidenē uoride (PVDF) membranes followed by immunoblot analysis. GST pull-down experiments from embryonic day 13 chicken retinas were performed as previously described (Dalva et al., 2000) .
Immunoprecipitation and immunoblot analysis
Chicken embryo brain and retina tissue were prepared as described for immunoblotting . Transfected cells were scraped in PBS from culture plates, centrifuged, and pellets were stored frozen. Cell pellets were lysed in Brij 97 buer (1% Brij 97, 20 mM Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 2 mM sodium pervanadate, 1 mM PMSF) for the experiments shown in Figure 4 or RIPA buer for the experiments shown in Figures 5 ± 7 , and sonicated. For immunoprecipitation, extracts were precleared for 30 min at 48C with Staph A (Boheringer ± Mannheim) (for immunoprecipitation with polyclonal antibodies) or protein Gsepharose (Pharmacia) (for immunoprecipitation with monoclonal antibodies). Extracts were then incubated with 5 mg polyclonal antibodies bound to Staph A or 5 mg monoclonal antibodies bound to protein G-sepharose. After washing with Brij or RIPA buer, the immunoprecipitates were separated by SDS-PAGE and transferred to PVDF membrane (Millipore Corp.) . For immunoblot analysis, ®lters were blocked for 1 h at room temperature with 3% BSA in TBST buer. Filters were incubated for 1 h at room temperature with primary antibodies and for 1 h with secondary antibodies. Primary and secondary antibodies were diluted at a concentration of 1 mg/ ml in 3% BSA in TBST buer. Detection was with an enhanced chemiluminescence system (Amersham). For reprobing with a dierent primary antibody, the immunoblots were stripped by a 40 min incubation at 508C with stripping buer (62.5 mM Tris, pH 7.5, 2% SDS, 100 mM b-mercaptoethanol). Membrane were then washed three times blocked and probed again with antibodies.
In vitro kinase assays
Endogenous Abl was immunoprecipitated from RIPA buer lysates and washed twice with kinase buer (25 mM Tris, pH 7.4, 10 mM MgCl 2 , 1 mM DTT) (Nehme et al., 1997) . Immunoprecipitated Abl bound to protein G beads was incubated at 268C for 30 min in 20 ml kinase buer containing 2 mg GST-Crk and 10 mM ATP. The reactions were terminated by addition of 10 ml SDS-containing sample buer and boiled for 10 min. The samples were then resolved by SDS ± PAGE and analysed by immunoblotting. The phosphorylation of GST-Crk was quantitated using NIH Image to analyse scans of the X-ray ®lms.
